Introduction: The risk of typical atrial flutter (AFL) is increased proportionately to right atrial (RA) size or right atrial scarring that results in reduced conduction velocity. These characteristics result in propagation of a flutter wave by ensuring the macro re-entrant wave front does not meet its refractory tail. The time taken to traverse the circuit would take account of both of these characteristics and may provide a novel marker of propensity to develop AFL. Our goal was to investigate right atrial collision time (RACT) as a marker of existing or future typical AFL. Methods: This single centre, prospective study recruited consecutive typical AFL ablation patients that were in sinus rhythm. Controls were consecutive electrophysiology study patients >18 years of age. While pacing the coronary sinus (CS) ostium at 600 ms, a local activation time map was created to locate the latest collision point on the anterolateral right atrial wall. This RACT is a measure of conduction velocity and distance from CS to a collision point on the lateral right atrial wall. Results: 98 patients were included in the analysis, 41 with atrial flutter and 57 controls. Patients with atrial flutter were older, 64.7 ± 9.7 vs 52.4 ± 16.8 years (<0.001) and more often male (34/41vs 31/57 (0.003)). The AFL group mean RACT (132.6±17.3 ms) was significantly longer than that of controls (99.1±11.6 ms) (p<0.001). A RACT cut-off of 115.5 ms had a sensitivity and specificity of 92.7% and 93.0% respectively for diagnosis of atrial flutter. An ROC curve indicated an AUC of 0.96 (95% CI: 0.93-1.0, p<0.01). Conclusion: RACT is a novel and promising marker of propensity for typical AFL. This data will inform larger prospective studies. The ability to predict AFL would be of significant clinical value to guide anticoagulation and ablation decisions.

Background: There is limited data on the safety and efficacy of a novel high-definition mapping catheter with 16 equidistant electrodes (Advisor HD Grid). We describe procedural details for the treatment of complex atrial arrhythmias and associated outcomes using this novel catheter design. Methods and Results: The HD Grid was employed for patients with clinically relevant arrhythmia using the EnSite Precision™ electroanatomic mapping system. AVRT and typical flutter cases were excluded. Major procedural complications were defined as bleeding, stroke or TIA, sepsis, and death from any cause, whereas minor complications were defined as no changes to the length of hospital stay or to the expected management of the patient. Recurrence was defined as sustained tachycardia after 3 months post-procedure. Consecutive patients attending for the treatment of paroxysmal atrial fibrillation (66), persistent atrial fibrillation (38), atrial tachycardia (29), and atypical flutter (18) were included, resulting in a final inclusion of 142 patients and 151 procedures. Eighty-four patients (55.3%) received general anesthetic and intracardiac echocardiography was used in 23 (15.1%). Long term follow-up was available in 150/151 procedures, mean 185.2±134.3 days; 32 patients (21.3%) documented recurrence. Three (2.0%) patients experienced complications within 30-days of the procedure including acute tamponade (1), TIA (1) and stroke (1) and 1 (0.7%) died from complications of septic arthritis 183 days post-procedure. Conclusion: The novel HD Grid differs significantly in design and handling compared to the traditional multielectrode catheters. Our data report procedural outcomes in line with contemporary clinical expectations with low complication and recurrence rates.